Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings
Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750....
Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750....
The Göppingen-based software group TeamViewer is riding a wave of sector-wide optimism, but beneath the surface, the company is grappling...
On paper, Ocugen has everything a small-cap biotech investor could want: seven buy ratings, zero holds or sells, and a...
Amazon shares closed the trading week at a fresh all-time high of $263.99, surging 3.42% on Friday alone as investors...
Elon Musk finally delivered the proof investors had been waiting for: the first driverless Cybercab has rolled off the production...
The calendar has thrown Deutsche Bank a curveball. On April 29, the Frankfurt-based lender will release its first-quarter results on...
Goldman Sachs has been tapped, a seven-person leadership team is in place, and the board has greenlit one of the...
The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...
Gold ended the week at roughly $4,725 an ounce, nursing a weekly loss of nearly 2.7%, yet the metal’s resilience...
The Munich-based insurer is navigating a curious dichotomy. Even as its asset management arm deepens its bet on the energy...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com